The leukemic stem cell niche: current concepts and therapeutic opportunities

Area of Science:

• Hematology
• Oncology
• Cancer Biology

Background:

• Genetic events in acute myeloid leukemia (AML) pathogenesis are well-understood, yet clinical outcomes have seen limited improvement.
• AML serves as a model for cancer stem cells (CSCs) with a hierarchical structure similar to normal hematopoiesis.
• Normal hematopoietic stem cells (HSCs) rely on bidirectional interactions with the bone marrow microenvironment (niche) for quiescence and self-renewal.

Purpose of the Study:

• To explore the role of the bone marrow microenvironment in supporting leukemia stem cell (LSC) survival.
• To understand how physiological interactions between HSCs and the niche inform LSC support mechanisms.
• To discuss rational therapeutic strategies targeting the bone marrow microenvironment in AML.

Main Methods:

• Review of emerging evidence on the bone marrow microenvironment's role in LSC survival.
• Analysis of physiological interactions between HSCs and the niche.
• Discussion of therapeutic approaches targeting the microenvironment.

Main Results:

• Leukemia stem cells (LSCs) may exploit homeostatic mechanisms within the bone marrow niche.
• The niche can provide sanctuary for LSCs during chemotherapy, contributing to disease relapse.
• Emerging evidence highlights the critical importance of the microenvironment in LSC maintenance.

Conclusions:

• The bone marrow microenvironment plays a crucial role in acute myeloid leukemia stem cell survival and therapeutic resistance.
• Understanding HSC-niche interactions provides insights into LSC support.
• Targeting the bone marrow microenvironment represents a rational strategy for developing novel AML therapies.